Sort
82,697 grants matching “vaccine development”
NIAID SPECIMEN REPOSITORY
$3,197,893Corinne Zeitler · Precision Bioservices, Inc. · N01 · FY2015 · AI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$3,197,781Ann R Falsey · University Of Rochester · UM1 · FY2021 · AI
Vaccine Induced Immunity in the Young and Aged
$3,197,242Rafi Ahmed · Emory University · U19 · FY2012 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$3,196,577Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Administrative Core
$3,194,965Barton F Haynes · Duke University · U19 · FY2020 · AI
CORE D: Animal Models and In Vivo Evaluation Core
$3,193,054Courtney Cohen · Albert Einstein College Of Medicine · U19 · FY2024 · AI
Manufacture an mRNA/LNP encoding an HIV envelope designed to bind and stimulate multiple V2 Apex broadly neutralizing antibody B cell lineages
$3,192,992Barton F Haynes · Duke University · UM1 · FY2024 · AI
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
$3,192,904Constance Ann Benson · University Of California, San Diego · UM1 · FY2013 · AI
Development of vaccines to bacterial diseases found especially in children
$3,188,737John Robbins · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
Maternal Immunization and Determinants of Infant Immunity
$3,188,570Marcela F Pasetti · University Of Maryland Baltimore · U19 · FY2021 · AI
HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027
$3,188,023Linda-Gail Bekker · University Of Cape Town · UM1 · FY2025 · AI
Reagent Resource Support Program for AIDS Vaccine Development
$3,184,911Valerie Fremont · Quality Biological, Inc. · N01 · FY2023 · AI
Vaccine Induced Immunity in the Young and Aged
$3,184,564Rafi Ahmed · Emory University · U19 · FY2009 · AI
Development of Technologies to Facilitate the Use of and Response to Vaccines
$3,183,629Dan Stinchcomb · Inviragen, Inc. · N01 · FY2013 · AI
Development/production of a Marburg rAd Vaccine
$3,180,682Kimberly Wallace · Niaid Extramural Activities · Z01 · FY2007 · AI
Development/production of H5 influenza DNA plasmid vaccine
$3,180,682Kimberly Wallace · Niaid Extramural Activities · Z01 · FY2007 · AI
Development/production of H3/H1 influenza DNA plasmid vaccine
$3,180,682Kimberly Wallace · Niaid Extramural Activities · Z01 · FY2007 · AI
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - SUPPORT FOR PRODUCTION AND TESTING OF ADC6-HIV GP140 AND ADC7-HIV GP140
$3,179,009Phillip Ishikawa · Advanced Bioscience Laboratories, Inc. · N01 · FY2016 · AI
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
$3,178,767Andrew Pekosz · Johns Hopkins University · N01 · FY2024 · AI
Immunobiology of Peanut Allergy and Its Treatment: A Prototype
$3,177,878Hugh Sampson · Icahn School Of Medicine At Mount Sinai · U19 · FY2007 · AI
Case AIDS Clinical Trials Unit
$3,176,040Michael Marcel Lederman · Case Western Reserve University · UM1 · FY2012 · AI
Cross-Protective Humoral Immunity to Coronavirus
$3,175,901Duane R. Wesemann · Brigham And Women'S Hospital · P01 · FY2023 · AI
Bone Marrow Grafting for Leukemia and Lymphoma
$3,175,580Robert S Negrin · Stanford University · P01 · FY2006 · CA
Vaccine and Treatment Evaluation Units
$3,175,510Nadine Georges Rouphael · Emory University · UM1 · FY2022 · AI
The Immunotherapy of Animal and Human Cancer
$3,172,648Steven A Rosenberg · Clinical Sciences · Z01 · FY2007 · CA